NATCO Pharma's Hyderabad API Manufacturing Facility Gets One Observation From USFDA
Natco Pharma Ltd. reported on Friday that its active pharmaceutical ingredient manufacturing facility in Mekaguda, Hyderabad, received one observation from the US Food And Drugs Administration which conducted an investigation, according to an exchange filing from the firm.
The investigation was conducted from June 9 to June 13, 2025.
The firm received one observation in the Form-483, which it deemed procedural in nature. It also said it would "address this observation comprehensively."
"The company remains committed to being Current Good Manufacturing Practices compliant and in supplying high-quality products to its customers and patients globally," the filing said.
The firm reported slower-than-expected earnings growth in the final quarter of Fiscal 2025.
Its consolidated, year-on-year net profit rose 5.3% to Rs 407 crore in the January-March quarter, compared to Rs 386 crore.
The bottom line was much lower than Bloomberg analysts' consensus estimate of Rs 587 crore.
For the full year, profit jumped 36% to Rs 1,883 crore from Rs 1,388.3 crore in Fiscal 2024.
Revenue from operations increased 14.3% to Rs 1,221 crore, missing the forecast of Rs 1,387 crore.
The firm's earnings before interest, taxes, depreciation, and amoritisation was up 10.2% to Rs 548 crore from Rs 497 crore in the year ago period.
In terms of operational profitability, higher expenses on raw materials pressured the company's Ebitda margin.
Shares of Natco Pharma closed 1.24% lower at Rs 912.70 apiece on the NSE, compared to a 1.1% fall in the benchmark Nifty. The stock has fallen 22.42% in the last 12 months and 34.21% on a year-to-date basis.
Out of 12 analysts tracking the company, five have a 'buy' rating on the stock, three recommend 'hold' and four suggest 'sell', according to Bloomberg data. The average of 12-month analysts' price target implies a potential upside of 6.5%.
-
Extracting Value From Battery Scrap Could Be Challenging For India | The Reason Why
A discarded lithium-ion battery still contains valuable materials such as lithium, nickel and cobalt. These can be recovered and reused. When such batteries are crushed and shredded, they produce a dark powder called black mass.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.